Evidence map›Paper›PMID 38641728›Full record

ArticleCell research2024

Structural basis for the recognition of HCoV-HKU1 by human TMPRSS2.

Lingyun Xia, Yuanyuan Zhang, Qiang Zhou

Open access · hybridAbstract readLetter
In one paragraph

Article in Cell research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Human coronavirus HKU1 neutralization by glycan receptor mimicry.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lingyun Xia *Center for Infectious Disease Research, Research Center for Industries of the Future, Zhejiang Key Laboratory of Structural Biology, School of Life Sciences, Westlake University. Institute of Biology, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
Yuanyuan Zhang *Center for Infectious Disease Research, Research Center for Industries of the Future, Zhejiang Key Laboratory of Structural Biology, School of Life Sciences, Westlake University. Institute of Biology, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
Qiang ZhouCenter for Infectious Disease Research, Research Center for Industries of the Future, Zhejiang Key Laboratory of Structural Biology, School of Life Sciences, Westlake University. Institute of Biology, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China. zhouqiang@westlake.edu.cn.ORCID 0000-0002-6237-8813
Westlake University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82241081
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Serine EndopeptidasesHumansProtein BindingSerine EndopeptidasesTMPRSS2 protein, human

Identifiers

PMID38641728
PMCPMC11217304
OpenAlexW4394962687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.